Company / Gross Margin
Enveric Biosciences, Inc. Gross Margin History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
20.9%
FY2019
5-year range
19.2% / 21.1%
FY2017-FY2019
Trend
-0.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin remained relatively stable over the past 3 years, with values between 19.2% and 21.1%.
Based on SEC 10-K filings.
20.9% in FY2019.
Improved from 19.2% to 20.9% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, gross margin decreased 0.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | 20.9% | -0.9% |
| FY2018 | 21.1% | +9.9% |
| FY2017 | 19.2% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026